Humberto Contreras-Trujillo
Affiliations: | 2009-2014 | Stanford University School of Medicine, Palo Alto, CA, United States |
Google:
"Humberto Contreras-Trujillo"Parents
Sign in to add mentorIrving L. Weissman | research assistant | 2009-2014 | Stanford Medical School | |
(CIRM Bridges Student) | ||||
Rong Lu | grad student | 2014- | University of Southern California Keck School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Contreras-Trujillo H, Eerdeng J, Akre S, et al. (2021) Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses. Nature Communications. 12: 6522 |
Cheah MT, Chen JY, Sahoo D, et al. (2015) CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: 4725-30 |
Rinkevich Y, Montoro DT, Contreras-Trujillo H, et al. (2014) In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Reports. 7: 1270-83 |
Tseng D, Volkmer JP, Willingham SB, et al. (2013) Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proceedings of the National Academy of Sciences of the United States of America. 110: 11103-8 |
Edris B, Willingham SB, Weiskopf K, et al. (2013) Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth. Proceedings of the National Academy of Sciences of the United States of America. 110: 3501-6 |
Edris B, Weiskopf K, Volkmer AK, et al. (2012) Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proceedings of the National Academy of Sciences of the United States of America. 109: 6656-61 |
Willingham SB, Volkmer JP, Gentles AJ, et al. (2012) The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proceedings of the National Academy of Sciences of the United States of America. 109: 6662-7 |
Volkmer JP, Sahoo D, Chin RK, et al. (2012) Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proceedings of the National Academy of Sciences of the United States of America. 109: 2078-83 |
Volkmer JP, Sahoo D, Chin RK, et al. (2012) Three differentiation states risk-stratify bladder cancer into distinct subtypes (Proceedings of the National Academy of Sciences of the United States of America (2012) 109, 6 (2078-2083) DOI: 10.1073/pnas.1120605109) Proceedings of the National Academy of Sciences of the United States of America. 109: 3600 |
Leman E, Huang W, Contreras-Trujillo H, et al. (2012) 1072 INHIBITION OF BLADDER CANCER CELL GROWTH BY TREATMENT WITH SYNTHETICALLY DERIVED ANTI-CANCER PEPTOIDS Journal of Urology. 187 |